Replacing habitual artificial sweetened beverage intake with water does not improve glycemic outcomes or HbA1c levels in patients with T2D.

In this study from ASCO GI 2026, researchers presented a 4-year follow-up of the phase 3 CheckMate 9DW trial of nivolumab plus ipilimumab in treatment-naïve HCC.

The FDA's policy regarding mifepristone aligned with recommendations made by the agency’s scientists from 2011 to 2023.

Higher antibody response toward Lachnospiraceae flagellin was associated with risk for CD among first-degree relatives of patients with CD.

Patients with colorectal cancer who walked as exercise after their diagnosis reported cancer-related fatigue and higher quality-of-life.